Jianfu Li , Shan Xiong , Ping He , Peng Liang , Caichen Li , Ran Zhong , Xiuyu Cai , Zhanhong Xie , Jun Liu , Bo Cheng , Zhuxing Chen , Hengrui Liang , Shen Lao , Zisheng Chen , Jiang Shi , Feng Li , Yi Feng , Zhenyu Huo , Hongsheng Deng , Ziwen Yu , Wenhua Liang
{"title":"空间全外显子组测序揭示肺腺癌高侵袭性成分的遗传特征","authors":"Jianfu Li , Shan Xiong , Ping He , Peng Liang , Caichen Li , Ran Zhong , Xiuyu Cai , Zhanhong Xie , Jun Liu , Bo Cheng , Zhuxing Chen , Hengrui Liang , Shen Lao , Zisheng Chen , Jiang Shi , Feng Li , Yi Feng , Zhenyu Huo , Hongsheng Deng , Ziwen Yu , Wenhua Liang","doi":"10.1016/j.neo.2024.101013","DOIUrl":null,"url":null,"abstract":"<div><p>In invasive lung adenocarcinoma (LUAD), patients with micropapillary (MIP) or solid (SOL) components had a significantly poorer prognosis than those with only lepidic (LEP), acinar (ACI) or papillary (PAP) components. It is interesting to explore the genetic features of different histologic subtypes, especially the highly aggressive components.</p><p>Based on a cohort of 5,933 patients, this study observed that in different tumor size groups, LUAD with MIP/SOL components showed a different prevalence, and patients with <em>ALK</em> alteration or <em>TP53</em> mutations had a higher probability of developing MIP/SOL components. To control individual differences, this research used spatial whole-exome sequencing (WES) via laser-capture microdissection of five patients harboring these five coexistent components and identified genetic features among different histologic components of the same tumor. In tracing the evolution of components, we found that <em>titin</em> (<em>TTN</em>) mutation might serve as a crucial intratumor potential driver for MIP/SOL components, which was validated by a cohort of 146 LUAD patients undergoing bulk WES. Functional analysis revealed that <em>TTN</em> mutations enriched the complement and coagulation cascades, which correlated with the pathway of cell adhesion, migration, and proliferation.</p><p>Collectively, the histologic subtypes of invasive LUAD were genetically different, and certain trunk genotypes might synergize with branching <em>TTN</em> mutation to develop highly aggressive components.</p></div>","PeriodicalId":18917,"journal":{"name":"Neoplasia","volume":"54 ","pages":"Article 101013"},"PeriodicalIF":4.8000,"publicationDate":"2024-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1476558624000551/pdfft?md5=5aac495b31b38eff0134e6452cba3364&pid=1-s2.0-S1476558624000551-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Spatial whole exome sequencing reveals the genetic features of highly-aggressive components in lung adenocarcinoma\",\"authors\":\"Jianfu Li , Shan Xiong , Ping He , Peng Liang , Caichen Li , Ran Zhong , Xiuyu Cai , Zhanhong Xie , Jun Liu , Bo Cheng , Zhuxing Chen , Hengrui Liang , Shen Lao , Zisheng Chen , Jiang Shi , Feng Li , Yi Feng , Zhenyu Huo , Hongsheng Deng , Ziwen Yu , Wenhua Liang\",\"doi\":\"10.1016/j.neo.2024.101013\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>In invasive lung adenocarcinoma (LUAD), patients with micropapillary (MIP) or solid (SOL) components had a significantly poorer prognosis than those with only lepidic (LEP), acinar (ACI) or papillary (PAP) components. It is interesting to explore the genetic features of different histologic subtypes, especially the highly aggressive components.</p><p>Based on a cohort of 5,933 patients, this study observed that in different tumor size groups, LUAD with MIP/SOL components showed a different prevalence, and patients with <em>ALK</em> alteration or <em>TP53</em> mutations had a higher probability of developing MIP/SOL components. To control individual differences, this research used spatial whole-exome sequencing (WES) via laser-capture microdissection of five patients harboring these five coexistent components and identified genetic features among different histologic components of the same tumor. In tracing the evolution of components, we found that <em>titin</em> (<em>TTN</em>) mutation might serve as a crucial intratumor potential driver for MIP/SOL components, which was validated by a cohort of 146 LUAD patients undergoing bulk WES. Functional analysis revealed that <em>TTN</em> mutations enriched the complement and coagulation cascades, which correlated with the pathway of cell adhesion, migration, and proliferation.</p><p>Collectively, the histologic subtypes of invasive LUAD were genetically different, and certain trunk genotypes might synergize with branching <em>TTN</em> mutation to develop highly aggressive components.</p></div>\",\"PeriodicalId\":18917,\"journal\":{\"name\":\"Neoplasia\",\"volume\":\"54 \",\"pages\":\"Article 101013\"},\"PeriodicalIF\":4.8000,\"publicationDate\":\"2024-06-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S1476558624000551/pdfft?md5=5aac495b31b38eff0134e6452cba3364&pid=1-s2.0-S1476558624000551-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neoplasia\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1476558624000551\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"Biochemistry, Genetics and Molecular Biology\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neoplasia","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1476558624000551","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
Spatial whole exome sequencing reveals the genetic features of highly-aggressive components in lung adenocarcinoma
In invasive lung adenocarcinoma (LUAD), patients with micropapillary (MIP) or solid (SOL) components had a significantly poorer prognosis than those with only lepidic (LEP), acinar (ACI) or papillary (PAP) components. It is interesting to explore the genetic features of different histologic subtypes, especially the highly aggressive components.
Based on a cohort of 5,933 patients, this study observed that in different tumor size groups, LUAD with MIP/SOL components showed a different prevalence, and patients with ALK alteration or TP53 mutations had a higher probability of developing MIP/SOL components. To control individual differences, this research used spatial whole-exome sequencing (WES) via laser-capture microdissection of five patients harboring these five coexistent components and identified genetic features among different histologic components of the same tumor. In tracing the evolution of components, we found that titin (TTN) mutation might serve as a crucial intratumor potential driver for MIP/SOL components, which was validated by a cohort of 146 LUAD patients undergoing bulk WES. Functional analysis revealed that TTN mutations enriched the complement and coagulation cascades, which correlated with the pathway of cell adhesion, migration, and proliferation.
Collectively, the histologic subtypes of invasive LUAD were genetically different, and certain trunk genotypes might synergize with branching TTN mutation to develop highly aggressive components.
期刊介绍:
Neoplasia publishes the results of novel investigations in all areas of oncology research. The title Neoplasia was chosen to convey the journal’s breadth, which encompasses the traditional disciplines of cancer research as well as emerging fields and interdisciplinary investigations. Neoplasia is interested in studies describing new molecular and genetic findings relating to the neoplastic phenotype and in laboratory and clinical studies demonstrating creative applications of advances in the basic sciences to risk assessment, prognostic indications, detection, diagnosis, and treatment. In addition to regular Research Reports, Neoplasia also publishes Reviews and Meeting Reports. Neoplasia is committed to ensuring a thorough, fair, and rapid review and publication schedule to further its mission of serving both the scientific and clinical communities by disseminating important data and ideas in cancer research.